Aclaris Therapeutics (ACRS) Goodwill (2017 - 2019)

Aclaris Therapeutics' Goodwill history runs 3 years deep, the most recent figure standing at $18.5 million for Q4 2019.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $18.5 million in Q4 2019; TTM through Dec 2019 was $18.5 million, a 0.0% change from a year earlier, with the FY2019 full-year figure at $18.5 million, changed 0.0% from the prior year.
• Goodwill steadied at $18.5 million in Q4 2019 per ACRS's latest filing, from $18.5 million in the prior quarter.
• Across five years, Goodwill topped out at $18.5 million in Q3 2017 and bottomed at $18.5 million in Q3 2017.
• The 3-year median for Goodwill is $18.5 million (2017), against an average of $18.5 million.
• Biggest YoY gain for Goodwill was 0.0% in 2018; the steepest drop was 0.0% in 2018.
• Year by year, Goodwill stood at $18.5 million in 2017, then changed by 0.0% to $18.5 million in 2018, then changed by 0.0% to $18.5 million in 2019.
• Per Business Quant, the three latest ACRS Goodwill figures stand at $18.5 million (Q4 2019), $18.5 million (Q1 2019), and $18.5 million (Q4 2018).